WESTON, Mass.--(BUSINESS WIRE)--Apr. 10, 2013--
Biogen Idec Inc. (NASDAQ:BIIB) today announced it will report first
quarter 2013 financial results on Thursday, April 25, 2013, before the
financial markets open.
Following the release of the financials, the Company will host a live
webcast where Biogen Idec management will discuss the financial results,
at 8:00 am ET. To access the live webcast, please go to the investor
relations section of Biogen Idec’s website at www.biogenidec.com.
Following the live webcast, an archived version of the call will be
available at the same URL, for one month.
About Biogen Idec
Through cutting-edge science and medicine, Biogen Idec discovers,
develops and delivers to patients worldwide innovative therapies for the
treatment of neurodegenerative diseases, hemophilia and autoimmune
disorders. Founded in 1978, Biogen Idec is the world’s oldest
independent biotechnology company. Patients worldwide benefit from its
leading multiple sclerosis therapies, and the company generates more
than $5 billion in annual revenues. For product labeling, press releases
and additional information about the company, please visit www.biogenidec.com.
Source: Biogen Idec Inc.
Karen Jewell, 781-464-2442